shRNA therapy (Tekmira/SomaGenics/Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameshRNA therapy (Tekmira/SomaGenics/Roche)
Drug Alias NameTKM-Hep CSG-220SG-237SG-273
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArbutus Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding LtdArbutus Biopharma CorpSomaGenics
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A